Optimization of cyclosporine monotherapy--long-term graft function.
Birkeland
S A
SA
Department of Nephrology, Odense University Hospital, Denmark.
Elbirk
A
A
Rohr
N
N
Jørgensen
K A
KA
D000328:Adult; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D001707:Biopsy, Needle; D002648:Child; D016572:Cyclosporine / Q000627:therapeutic use*; D003586:Cytomegalovirus Infections / Q000188:drug therapy; D005500:Follow-Up Studies; D015774:Ganciclovir / Q000627:therapeutic use; D006084:Graft Rejection / Q000628:therapy; D006085:Graft Survival / Q000276:immunology / Q000502:physiology; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods*; D016030:Kidney Transplantation / Q000276:immunology* / Q000473:pathology / Q000502:physiology; D008991:Monitoring, Physiologic; D016853:Muromonab-CD3 / Q000627:therapeutic use; D011183:Postoperative Complications / Q000188:drug therapy / Q000517:prevention & control; D011239:Prednisolone / Q000627:therapeutic use; D012189:Retrospective Studies; D013997:Time Factors
D000961:Antilymphocyte Serum; D016853:Muromonab-CD3; D016572:Cyclosporine; D011239:Prednisolone; D015774:Ganciclovir